VanEck Biotech Stock Options

BBH Etf  USD 157.15  2.56  1.66%   
VanEck Biotech's option chain provides insight into all available option contracts written on VanEck Biotech's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of VanEck Biotech's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given VanEck option contract.

In The Money vs. Out of Money Option Contracts on VanEck Biotech

Analyzing VanEck Biotech's in-the-money options over time can help investors to take a profitable long position in VanEck Biotech regardless of its overall volatility. This is especially true when VanEck Biotech's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money VanEck Biotech's options could be used as guardians of the underlying stock as they move almost dollar for dollar with VanEck Biotech's stock while costing only a fraction of its price.
VanEck Biotech's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 62 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The VanEck Biotech option chain provides detailed quote and price information for the current VanEck Biotech ETF option contracts. It shows all of VanEck Biotech's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows VanEck Biotech's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. VanEck Biotech's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for VanEck Biotech's option, there is no secondary market available for investors to trade.

VanEck Biotech Maximum Pain Price across 2024-05-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as VanEck Biotech close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
VanEck Biotech's stock options are financial instruments that give investors the right to buy or sell shares of VanEck Biotech ETF common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell VanEck stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If VanEck Biotech's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please note that buying 'in-the-money' options on VanEck Biotech lessens the impact of time decay, as they carry both intrinsic and time value. So, even if VanEck Biotech's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money VanEck Biotech contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if VanEck Etf moves the wrong way.

VanEck Biotech ETF In The Money Call Balance

When VanEck Biotech's strike price is surpassing the current stock price, the option contract against VanEck Biotech ETF stock is said to be in the money. When it comes to buying VanEck Biotech's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on VanEck Biotech ETF are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

VanEck Current Options Market Mood

VanEck Biotech's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps VanEck Etf's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of VanEck Biotech's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. VanEck Biotech's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current VanEck Biotech's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current VanEck contract

Base on the Rule 16, the options market is currently suggesting that VanEck Biotech ETF will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-05-17 option contract. With VanEck Biotech trading at USD 157.15, that is roughly USD 0.0. If you think that the market is fully incorporating VanEck Biotech's daily price movement you should consider buying VanEck Biotech ETF options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing VanEck Biotech options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" VanEck calls. Remember, the seller must deliver VanEck Biotech ETF stock to the call owner when a call is exercised.

VanEck Biotech Option Chain

When VanEck Biotech's strike price is surpassing the current stock price, the option contract against VanEck Biotech ETF stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
VanEck Biotech's option chain is a display of a range of information that helps investors for ways to trade options on VanEck. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for VanEck. It also shows strike prices and maturity days for a VanEck Biotech against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-05-17 CALL at $147.00.75720.035102024-05-175.7 - 8.60.0In
Call
2024-05-17 CALL at $148.00.72150.038102024-05-174.9 - 7.90.0In
Call
2024-05-17 CALL at $149.00.68970.042402024-05-174.1 - 7.00.0In
Call
2024-05-17 CALL at $150.00.64350.044102024-05-173.4 - 6.50.0In
Call
2024-05-17 CALL at $151.00.60230.048302024-05-172.95 - 5.40.0In
Call
2024-05-17 CALL at $152.00.55320.049802024-05-172.3 - 4.90.0In
Call
2024-05-17 CALL at $153.00.5030.050602024-05-171.75 - 4.40.0In
Call
2024-05-17 CALL at $154.00.45140.051402024-05-171.2 - 3.90.0In
Call
2024-05-17 CALL at $155.00.40050.050502024-05-170.75 - 3.50.0Out
Call
2024-05-17 CALL at $156.00.35090.048702024-05-170.4 - 3.10.0Out
Call
2024-05-17 CALL at $157.00.30350.046202024-05-170.1 - 2.750.0Out
Call
2024-05-17 CALL at $162.00.16470.028102024-05-170.05 - 1.450.0Out
 Put
2024-05-17 PUT at $147.0-0.24840.035202024-05-170.1 - 2.650.0Out
 Put
2024-05-17 PUT at $148.0-0.28410.038102024-05-170.3 - 2.950.0Out
 Put
2024-05-17 PUT at $149.0-0.32450.040402024-05-170.6 - 3.30.0Out
 Put
2024-05-17 PUT at $150.0-0.36480.05202024-05-170.9 - 3.60.0Out
 Put
2024-05-17 PUT at $151.0-0.40960.044802024-05-171.3 - 4.00.0Out
 Put
2024-05-17 PUT at $152.0-0.45540.046202024-05-171.75 - 4.40.0Out
 Put
2024-05-17 PUT at $153.0-0.50240.047602024-05-172.2 - 4.80.0Out
 Put
2024-05-17 PUT at $154.0-0.55030.061302024-05-172.8 - 5.30.0Out
 Put
2024-05-17 PUT at $155.0-0.59510.065902024-05-173.4 - 6.00.0In
 Put
2024-05-17 PUT at $156.0-0.62110.039702024-05-174.1 - 7.40.0In
 Put
2024-05-17 PUT at $157.0-0.69260.043502024-05-173.6 - 8.20.0In
 Put
2024-05-17 PUT at $158.0-0.69520.036402024-05-175.3 - 9.00.0In
 Put
2024-05-17 PUT at $159.0-0.76280.036902024-05-175.1 - 9.90.0In
 Put
2024-05-17 PUT at $160.0-0.84520.033402024-05-175.9 - 10.14.2In
 Put
2024-05-17 PUT at $161.0-0.78840.029802024-05-177.5 - 11.50.0In
 Put
2024-05-17 PUT at $162.0-0.82770.027202024-05-178.0 - 12.50.0In
 Put
2024-05-17 PUT at $163.0-0.83590.024702024-05-179.0 - 13.50.0In
 Put
2024-05-17 PUT at $164.0-0.85910.022602024-05-179.7 - 14.50.0In
 Put
2024-05-17 PUT at $165.0-0.88160.019902024-05-1711.0 - 15.00.0In
 Put
2024-05-17 PUT at $166.0-0.88640.018302024-05-1712.0 - 16.00.0In
 Put
2024-05-17 PUT at $167.0-0.89080.01702024-05-1713.0 - 17.00.0In
 Put
2024-05-17 PUT at $168.0-0.88780.016102024-05-1714.1 - 18.00.0In
 Put
2024-05-17 PUT at $169.0-0.92210.013202024-05-1714.7 - 19.00.0In
 Put
2024-05-17 PUT at $170.0-0.93330.011602024-05-1715.6 - 20.00.0In
 Put
2024-05-17 PUT at $171.0-0.93550.010902024-05-1716.6 - 21.00.0In
 Put
2024-05-17 PUT at $172.0-0.98290.00402024-05-1717.5 - 21.80.0In
 Put
2024-05-17 PUT at $173.0-0.9480.008902024-05-1718.5 - 23.00.0In
 Put
2024-05-17 PUT at $174.0-0.94940.008402024-05-1719.9 - 23.60.0In
 Put
2024-05-17 PUT at $175.0-0.94250.008602024-05-1720.6 - 25.00.0In
 Put
2024-05-17 PUT at $176.0-0.9360.008802024-05-1721.7 - 26.00.0In
 Put
2024-05-17 PUT at $177.0-0.94520.007802024-05-1722.6 - 27.00.0In

Be your own money manager

Our tools can tell you how much better you can do entering a position in VanEck Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Already Invested in VanEck Biotech ETF?

The danger of trading VanEck Biotech ETF is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of VanEck Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than VanEck Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile VanEck Biotech ETF is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.